Shingrix, the new shingles vaccine, is over 90 percent effective in preventing the painful viral infection Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything from the NFL ...

It was replaced by Shingrix, a recombinant vaccine that uses a protein from the varicella-zoster virus to activate the body’s immune system to recognize and fight the virus. Shingrix has been ...

Shingrix was hit hard in the first quarter as a result of the prioritisation of COVID-19 vaccination programmes in the US and other markets, with sales dropping almost 50% to £327 million, but ...

The Recombinant Zoster vaccine (RZV, commercially known as SHINGRIX TM) offers strong protection against shingles, but there’s still a lot we don’t understand about how the immune system prevents ...

Who should get it? Wen: The US Centers for Disease Control and Prevention recommends two doses of the recombinant zoster vaccine, called Shingrix, for adults 50 and older . This age recommendation ...

Vaccination with GSK's recombinant shingles vaccine, Shingrix, could delay the onset of dementia, according to researchers in the UK. A study published in Nature Medicine suggests that people ...

Sareen, PharmDMedically reviewed by Gurdeep S. Sareen, PharmD The second dose of Shingrix (recombinant zoster vaccine) may cause side effects that are worse than the first. The second dose is ...

Questions and answers are republished by permission. Q: I had the two doses of the Shingrix vaccine in 2018 for shingles. I’m 77 years old. Does its effectiveness wane? Should I have another ...